DS-1103a

DRUG2 trials

Sponsors

Daiichi Sankyo

Conditions

Advanced Solid TumorLocally Advanced Non-Small Cell Lung CancerMetastatic Non-Small Cell Lung CancerSolid Tumor

Phase 1

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

RecruitingNCT05765851

Daiichi SankyoAdvanced Solid Tumor

Start: 2023-05-30End: 2030-05-15Target: 108Updated: 2026-08-21

A Study of DS-3939a in Participants With Solid Tumors

Not yet recruitingNCT07739966

Daiichi SankyoSolid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

Start: 2026-10-01End: 2032-01-29Target: 400Updated: 2026-07-31